Mechanistic insights on mogrosides as bifunctional regulators of metabolic reprogramming and immune modulation in tumor microenvironment
Cancer Immunology, Immunotherapy · 2026
DOI: 10.1007/s00262-026-04478-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Meghna Patial und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences and Technology (SoHST), UPES, Dehradun, 248007, India. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Triterpenes, Immunomodulation. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aalto University.
Abstract (Originalsprache)
Metabolic reprogramming and immune evasion are interconnected hallmarks of cancer that sustain tumor progression and therapeutic resistance. This review summarizes current mechanistic evidence supporting the therapeutic potential of mogrosides, derived from the fruits of Siraitia grosvenorii, as multi-functional agents with dual roles in regulating tumor metabolism and immune responses. Mechanistically, mogrosides are potent AMPK activators that attenuate the Warburg effect, suppress PI3K/AKT/mTOR signaling, and inhibit de novo lipogenesis. Also, mogrosides suppress lactate accumulation within the tumor microenvironment. In parallel, they modulate immune responses through inhibition of STAT3 and NF-κB signaling pathways, resulting in reduced pro-inflammatory cytokine production and decreased PD-L1 expression. Additionally, mogrosides interfere with oncogenic signaling cascades including JAK/STAT3 and MAPK/ERK that regulate proliferation and survival. They further suppress epithelial-mesenchymal transition and matrix metalloproteinase expression, limiting metastatic potential. By simultaneously targeting metabolic plasticity and immune suppression, mogrosides represent promising adjuvant candidates in cancer therapy; however, further clinical investigations are required to validate their translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Sciences and Technology (SoHST), UPES, Dehradun, 248007, India.
- Division of Biotechnology, CSIR-Institute of Himalayan Bioresource Technology, Palampur, India.
- Academy of Scientific and Innovative Research (AcSIR), CSIR-HRDC Campus, Ghaziabad, Uttar Pradesh, India.
- Chemistry and Bioprospecting Division, Forest Research Institute, Dehradun, 248006, India.
- Department of Applied Physics, School of Science, Aalto University, Puumiehenkuja 2, FIN-02150 Espoo, Finland.
- University Center for Research and Development, Chandigarh University, Mohali, Punjab, India. kavindra.kesari@aalto.fi.
Förderung
- Aalto University
Zitieren
APA
Patial, M., Joshi, R., Rajput, J., Kumar, V., Ruokolainen, J., Kesari, K. K., & Kumar, D. (2026). Mechanistic insights on mogrosides as bifunctional regulators of metabolic reprogramming and immune modulation in tumor microenvironment. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04478-w
Vancouver
Patial M, Joshi R, Rajput J, Kumar V, Ruokolainen J, Kesari KK, et al. Mechanistic insights on mogrosides as bifunctional regulators of metabolic reprogramming and immune modulation in tumor microenvironment. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04478-w
BibTeX
@article{Patial2026,
author = {Patial, Meghna and Joshi, Rohit and Rajput, Jyoti and Kumar, Vineet and Ruokolainen, Janne and Kesari, Kavindra Kumar and Kumar, Dhruv},
title = {Mechanistic insights on mogrosides as bifunctional regulators of metabolic reprogramming and immune modulation in tumor microenvironment},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
doi = {10.1007/s00262-026-04478-w}
}
EUVIMED